Marcelo Luiz Campos Vieira, Ana C T Rodrigues, Edgar Daminello, Adriana Reche, Gustavo P de Almeida, Alessandra J Oliveira, Luiz O A Santos, Rafael B Piveta, Rodrigo A C Meirelles, Cláudia G Monaco, Fernando C Oliveira, Fernando A Solis, Wercules Oliveira, Alessandro C Lianza, Adriana Sanudo, Edgar B Lira Filho, Sérgio A F Curcio, Robinson Poffo, Cláudio H Fischer, Samira S Morhy
{"title":"Automatic transesophageal echocardiographic evaluation of patients with mitral valve prolapse: comparison with patients without structural cardiac chamber remodeling (an exploratory study).","authors":"Marcelo Luiz Campos Vieira, Ana C T Rodrigues, Edgar Daminello, Adriana Reche, Gustavo P de Almeida, Alessandra J Oliveira, Luiz O A Santos, Rafael B Piveta, Rodrigo A C Meirelles, Cláudia G Monaco, Fernando C Oliveira, Fernando A Solis, Wercules Oliveira, Alessandro C Lianza, Adriana Sanudo, Edgar B Lira Filho, Sérgio A F Curcio, Robinson Poffo, Cláudio H Fischer, Samira S Morhy","doi":"10.21037/jtd-2026-1300","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of information concerning automatic mitral valve apparatus (MVA) analysis of patients with mitral valve prolapse (MVP). We aimed to study with an automatic three-dimensional (3D) transesophageal echocardiography (TEE)-dedicated software, patients with moderate and severe mitral regurgitation when compared to patients with no structural cardiac chamber alterations [patients with patent foramen ovale (PFO) who underwent TEE].</p><p><strong>Methods: </strong>We employed TEE software dedicated to automatic analysis of 34 parameters of the MVA, comparing MVP patients with moderate and severe mitral regurgitation and patients with PFO without cardiac chamber structural alterations. Mitral valve effective regurgitant orifice (ERO) and regurgitant volume were correlated to automatic MVP parameters.</p><p><strong>Results: </strong>Fifty-nine MVP patients and 43 PFO patients were analyzed. All MVP patients presented P2 MVP, 15 (25.4%) with both posterior and anterior prolapse. Twenty-seven automatic parameters (79%) were different concerning MVP and PFO patients (P<0.05): diameters, area, perimeter, height, angle, coaptation width, length, closure line length, and annulus. ERO was 0.43±0.11 cm<sup>2</sup>, and regurgitant volume was 62.9±14.9 mL/beat. Automatic analysis correlated to 75<sup>th</sup> percentile ERO MVP patients (ERO >0.48 cm<sup>2</sup>): posterior leaflet area (r=0.74, P=0.03); posterior leaflet length (r=0.73, P=0.03); tenting area (r=0.41, P=0.048).</p><p><strong>Conclusions: </strong>Automatic mitral valve parameters differed significantly between patients with MVP and those without structural cardiac chamber remodeling. In exploratory analysis, patients in the upper range of ERO values (≥75<sup>th</sup> percentile) showed patterns involving posterior leaflet geometry that were consistent with the associations observed in continuous-variable analysis. These findings support the potential role of automated 3D assessment in the anatomical characterization of MVP.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"18 9","pages":"1038"},"PeriodicalIF":2.3000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655812/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-2026-1300","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There is a paucity of information concerning automatic mitral valve apparatus (MVA) analysis of patients with mitral valve prolapse (MVP). We aimed to study with an automatic three-dimensional (3D) transesophageal echocardiography (TEE)-dedicated software, patients with moderate and severe mitral regurgitation when compared to patients with no structural cardiac chamber alterations [patients with patent foramen ovale (PFO) who underwent TEE].
Methods: We employed TEE software dedicated to automatic analysis of 34 parameters of the MVA, comparing MVP patients with moderate and severe mitral regurgitation and patients with PFO without cardiac chamber structural alterations. Mitral valve effective regurgitant orifice (ERO) and regurgitant volume were correlated to automatic MVP parameters.
Results: Fifty-nine MVP patients and 43 PFO patients were analyzed. All MVP patients presented P2 MVP, 15 (25.4%) with both posterior and anterior prolapse. Twenty-seven automatic parameters (79%) were different concerning MVP and PFO patients (P<0.05): diameters, area, perimeter, height, angle, coaptation width, length, closure line length, and annulus. ERO was 0.43±0.11 cm2, and regurgitant volume was 62.9±14.9 mL/beat. Automatic analysis correlated to 75th percentile ERO MVP patients (ERO >0.48 cm2): posterior leaflet area (r=0.74, P=0.03); posterior leaflet length (r=0.73, P=0.03); tenting area (r=0.41, P=0.048).
Conclusions: Automatic mitral valve parameters differed significantly between patients with MVP and those without structural cardiac chamber remodeling. In exploratory analysis, patients in the upper range of ERO values (≥75th percentile) showed patterns involving posterior leaflet geometry that were consistent with the associations observed in continuous-variable analysis. These findings support the potential role of automated 3D assessment in the anatomical characterization of MVP.
期刊介绍:
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.